resveratrol has been researched along with Ganglioside Storage Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breier, AC; Kreutz, F; Matté, A; Netto, CA; Salbego, CG; Simão, F; Trindade, VM | 1 |
1 other study(ies) available for resveratrol and Ganglioside Storage Diseases
| Article | Year |
|---|---|
Resveratrol prevents global cerebral ischemia-induced decrease in lipid content.
Topics: Animals; Antioxidants; Brain Ischemia; Cholesterol; Chromatography, Thin Layer; Disease Models, Animal; Gangliosidoses; Lipid Metabolism Disorders; Male; Phospholipids; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2013 |